TSPACETHERAPY LIMITED
Company number 15611294 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
TSPACETHERAPY LIMITED - Analysis Report
Company Number: 15611294
Analysis Date: 2025-07-29 12:18 UTC
Financial Health Assessment for TSPACETHERAPY LIMITED
1. Financial Health Score: B
Explanation:
Given the company’s very recent incorporation (April 2024) and the micro-entity status, the financial metrics available show a stable but very early-stage financial position. The company exhibits a positive net asset position, modest working capital, and no overdue filings, suggesting good initial financial hygiene. However, the scale is small, and the business is in the nascent phase, limiting the scope for a higher grade until more operational history and revenue data emerge.
2. Key Vital Signs
| Metric | Value (£) | Interpretation |
|---|---|---|
| Current Assets | 483 | Indicates liquid or near-liquid resources available to cover short-term obligations. Healthy at this scale. |
| Current Liabilities | 92 | Short-term debts are very low, suggesting limited immediate financial pressure. |
| Net Current Assets | 391 | Positive working capital ("healthy cash flow buffer") indicating ability to meet short-term liabilities. |
| Net Assets (Equity) | 391 | Positive net worth, showing assets exceed liabilities, a "healthy heart" of the company. |
| Number of Employees | 1 | Very small operation, reflecting micro-entity scale and low overheads. |
3. Diagnosis
The company is in a stable early stage with a "healthy cash flow pulse" demonstrated by positive net current assets and net equity. The absence of liabilities beyond the short term and minimal overheads (one employee, the director herself) reduces financial strain. The company structure is straightforward with a single person controlling 75-100% of shares and management, simplifying governance but also concentrating risk.
The financial "symptoms" reflect a start-up in its infancy:
- Limited asset base but no signs of distress or over-leverage.
- No overdue filings, indicating good compliance and management discipline.
- Micro-entity filing exemptions utilized appropriately, showing cost-conscious financial administration.
However, the company’s small scale and very early stage limit its resilience. It lacks diversified income streams and has minimal working capital, which could become a "symptom of distress" if unexpected expenses or revenue shortfalls occur.
4. Recommendations
- Build Cash Reserves: Aim to increase current assets (cash or receivables) to strengthen the working capital buffer and absorb operational shocks.
- Revenue Growth Focus: Develop client base and service offerings to increase turnover, enhancing long-term financial sustainability.
- Monitor Overheads Carefully: Maintain low fixed costs relative to income to preserve financial flexibility.
- Regular Financial Reviews: Conduct periodic internal reviews of cash flow and liabilities to quickly identify any emerging financial "symptoms."
- Consider External Funding: If growth plans accelerate, assess options for external funding to avoid financial strain on owner’s equity.
- Compliance Vigilance: Continue timely filing of accounts and confirmation statements to avoid penalties and maintain good standing.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.